
Apogee Therapeutics
Develops advanced biologics for treating inflammatory and immune diseases like atopic dermatitis and asthma.
Market cap
$2.5b
Enterprise value
$2.0b
Share price
$43.43 APGE
Authorizing premium user...
Develops advanced biologics for treating inflammatory and immune diseases like atopic dermatitis and asthma.